160 related articles for article (PubMed ID: 34501382)
1. Characterisation of Non-Pathogenic Premutation-Range Myotonic Dystrophy Type 2 Alleles.
Radvanszky J; Hyblova M; Radvanska E; Spalek P; Valachova A; Magyarova G; Bognar C; Polak E; Szemes T; Kadasi L
J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501382
[TBL] [Abstract][Full Text] [Related]
2. Uninterrupted CCTG tracts in the myotonic dystrophy type 2 associated locus.
Radvanszky J; Surovy M; Polak E; Kadasi L
Neuromuscul Disord; 2013 Jul; 23(7):591-8. PubMed ID: 23561036
[TBL] [Abstract][Full Text] [Related]
3. Premutation allele pool in myotonic dystrophy type 2.
Bachinski LL; Czernuszewicz T; Ramagli LS; Suominen T; Shriver MD; Udd B; Siciliano MJ; Krahe R
Neurology; 2009 Feb; 72(6):490-7. PubMed ID: 19020295
[TBL] [Abstract][Full Text] [Related]
4. Distribution and Structure of DM2 Repeat Tract Alleles in the German Population.
Mahyera AS; Schneider T; Halliger-Keller B; Schrooten K; Hörner EM; Rost S; Kress W
Front Neurol; 2018; 9():463. PubMed ID: 29973908
[TBL] [Abstract][Full Text] [Related]
5. Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract.
Liquori CL; Ikeda Y; Weatherspoon M; Ricker K; Schoser BG; Dalton JC; Day JW; Ranum LP
Am J Hum Genet; 2003 Oct; 73(4):849-62. PubMed ID: 14505273
[TBL] [Abstract][Full Text] [Related]
6. Characterization of full-length
Alfano M; De Antoni L; Centofanti F; Visconti VV; Maestri S; Degli Esposti C; Massa R; D'Apice MR; Novelli G; Delledonne M; Botta A; Rossato M
Elife; 2022 Aug; 11():. PubMed ID: 36018009
[TBL] [Abstract][Full Text] [Related]
7. A 14-Year Italian Experience in DM2 Genetic Testing: Frequency and Distribution of Normal and Premutated
Botta A; Visconti VV; Fontana L; Bisceglia P; Bengala M; Massa R; Bagni I; Cardani R; Sangiuolo F; Meola G; Antonini G; Petrucci A; Pegoraro E; D'Apice MR; Novelli G
Front Genet; 2021; 12():668094. PubMed ID: 34234810
[TBL] [Abstract][Full Text] [Related]
8. Expanded [CCTG]n repetitions are not associated with abnormal methylation at the CNBP locus in myotonic dystrophy type 2 (DM2) patients.
Santoro M; Fontana L; Maiorca F; Centofanti F; Massa R; Silvestri G; Novelli G; Botta A
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):917-924. PubMed ID: 29291944
[TBL] [Abstract][Full Text] [Related]
9. Effects of interrupting residues on DNA dumbbell structures formed by CCTG tetranucleotide repeats associated with myotonic dystrophy type 2.
Yang Y; Wang Y; Yan Z; Li Z; Guo P
FEBS Lett; 2024 Jun; ():. PubMed ID: 38922834
[TBL] [Abstract][Full Text] [Related]
10. Repeat-primed polymerase chain reaction in myotonic dystrophy type 2 testing.
Radvansky J; Ficek A; Kadasi L
Genet Test Mol Biomarkers; 2011 Mar; 15(3):133-6. PubMed ID: 21204698
[TBL] [Abstract][Full Text] [Related]
11. Unusual structures of CCTG repeats and their participation in repeat expansion.
Guo P; Lam SL
Biomol Concepts; 2016 Dec; 7(5-6):331-340. PubMed ID: 27879482
[TBL] [Abstract][Full Text] [Related]
12. Reduction of Cellular Nucleic Acid Binding Protein Encoded by a Myotonic Dystrophy Type 2 Gene Causes Muscle Atrophy.
Wei C; Stock L; Schneider-Gold C; Sommer C; Timchenko NA; Timchenko L
Mol Cell Biol; 2018 Jul; 38(14):. PubMed ID: 29735719
[TBL] [Abstract][Full Text] [Related]
13. The unstable CCTG repeat responsible for myotonic dystrophy type 2 originates from an AluSx element insertion into an early primate genome.
Kurosaki T; Ueda S; Ishida T; Abe K; Ohno K; Matsuura T
PLoS One; 2012; 7(6):e38379. PubMed ID: 22723857
[TBL] [Abstract][Full Text] [Related]
14. Unexpected diagnosis of myotonic dystrophy type 2 repeat expansion by genome sequencing.
Rafehi H; Green C; Bozaoglu K; Gillies G; Delatycki MB; Lockhart PJ; Scheffer IE; Bahlo M
Eur J Hum Genet; 2023 Jan; 31(1):122-124. PubMed ID: 35945246
[TBL] [Abstract][Full Text] [Related]
15. Analysis of repetitive regions in myotonic dystrophy type 1 and 2.
Carson NL
Curr Protoc Hum Genet; 2009 Apr; Chapter 9():Unit 9.6. PubMed ID: 19360700
[TBL] [Abstract][Full Text] [Related]
16. Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect.
Bachinski LL; Udd B; Meola G; Sansone V; Bassez G; Eymard B; Thornton CA; Moxley RT; Harper PS; Rogers MT; Jurkat-Rott K; Lehmann-Horn F; Wieser T; Gamez J; Navarro C; Bottani A; Kohler A; Shriver MD; Sallinen R; Wessman M; Zhang S; Wright FA; Krahe R
Am J Hum Genet; 2003 Oct; 73(4):835-48. PubMed ID: 12970845
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a relatively high proportion of DM2 mutations in a large group of Polish patients.
Sulek A; Lusakowska A; Krysa W; Rajkiewicz M; Kaminska A; Nojszewska M; Kostera-Pruszczyk A; Zdzienicka E; Kubalska J; Rakowicz M; Szirkowiec W; Kwiecinski H; Zaremba J
Neurol Neurochir Pol; 2018; 52(6):736-742. PubMed ID: 29588063
[TBL] [Abstract][Full Text] [Related]
18. Molecular Diagnosis of Myotonic Dystrophy.
Chakraborty S; Vatta M; Bachinski LL; Krahe R; Dlouhy S; Bai S
Curr Protoc Hum Genet; 2016 Oct; 91():9.29.1-9.29.19. PubMed ID: 27727437
[TBL] [Abstract][Full Text] [Related]
19. Massive contractions of myotonic dystrophy type 2-associated CCTG tetranucleotide repeats occur via double-strand break repair with distinct requirements for DNA helicases.
Papp D; Hernandez LA; Mai TA; Haanen TJ; O'Donnell MA; Duran AT; Hernandez SM; Narvanto JE; Arguello B; Onwukwe MO; Mirkin SM; Kim JC
G3 (Bethesda); 2024 Feb; 14(2):. PubMed ID: 37950892
[TBL] [Abstract][Full Text] [Related]
20. Hairpin structure-forming propensity of the (CCTG.CAGG) tetranucleotide repeats contributes to the genetic instability associated with myotonic dystrophy type 2.
Dere R; Napierala M; Ranum LP; Wells RD
J Biol Chem; 2004 Oct; 279(40):41715-26. PubMed ID: 15292165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]